Generalized anxiety patients were randomly allocated to Cognitive-Behaviour Therapy, Diazepam or Placebo and managed in a primary care setting. Treatments were balanced for degree of psychologist/patient contact. A range of outcome measures, including patient self report, psychologist assessor and general practitioner ratings were used. Large variations within group response to treatment emerged. At the end of active treatment the superiority of Cognitive-Behaviour Therapy was suggested. Post-study psychotropic prescription and psychological treatment was assessed at a 12-month follow-up. The Cognitive-Behaviour group revealed the lowest incidence of subsequent treatment interventions.
A psychological test battery briefly assessing memory, intelligence, and attention was administered to 10 delinquent solvent inhalers and 10 matched controls. The solvent abuse group showed significant impairment in tests of memory, nonverbal intelligence, and attention and concentration. The implications for future research are discussed.
Repertory grids were used to investigate self-esteem and social perception in three groups: depressed in-patients, non-depressed psychiatric in-patients and a general hospital control group. Depression was measured by the Beck Depression Inventory. Depressives had significantly lower self-esteem and more negative social perception and negative feelings associated with 'actual self', as predicted by Beck's cognitive theory. Repertory grids are potentially useful tools for the development of cognitive theories of depression, and may also have a role in clinical practice using cognitive techniques.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.